Related references
Note: Only part of the references are listed.Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
Merryn Voysey et al.
LANCET (2021)
Interim Results of a Phase 1-2a Trial of Ad26.COV2.S Covid-19 Vaccine
J. Sadoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Evolving Status of Clinical Immunotherapy with Oncolytic Adenovirus
Marti Farrera-Sal et al.
CLINICAL CANCER RESEARCH (2021)
Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia
Denis Y. Logunov et al.
LANCET (2021)
Cancer imaging and therapy utilizing a novel NIS-expressing adenovirus: The role of adenovirus death protein deletion
Matthew Glen Robertson et al.
MOLECULAR THERAPY-ONCOLYTICS (2021)
Safety, tolerability and immunogenicity of V934/V935 hTERT vaccination in cancer patients with selected solid tumors: a phase I study
Luigi Aurisicchio et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2020)
Genetic Adjuvants in Replicating Single-Cycle Adenovirus Vectors Amplify Systemic and Mucosal Immune Responses against HIV-1 Envelope
William E. Matchett et al.
VACCINES (2020)
The coxsackievirus and adenovirus receptor: virological and biological beauty
Katherine J. D. A. Excoffon
FEBS LETTERS (2020)
Factors Which Contribute to the Immunogenicity of Non-replicating Adenoviral Vectored Vaccines
Lynda Coughlan
FRONTIERS IN IMMUNOLOGY (2020)
Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial
Feng-Cai Zhu et al.
LANCET (2020)
A Replicating Single-Cycle Adenovirus Vaccine Effective against Clostridium difficile
William E. Matchett et al.
VACCINES (2020)
Divergent HIV-1-Directed Immune Responses Generated by Systemic and Mucosal Immunization with Replicating Single-Cycle Adenoviruses in Rhesus Macaques
William E. Matchett et al.
JOURNAL OF VIROLOGY (2019)
Rodents Versus Pig Model for Assessing the Performance of Serotype Chimeric Ad5/3 Oncolytic Adenoviruses
Lisa Koodie et al.
CANCERS (2019)
A review of 65 years of human adenovirus seroprevalence
Franck J. D. Mennechet et al.
EXPERT REVIEW OF VACCINES (2019)
A tumor targeting oncolytic adenovirus can improve therapeutic outcomes in chemotherapy resistant metastatic human breast carcinoma
Ali Sakhawat et al.
SCIENTIFIC REPORTS (2019)
Adenovirus Entry: From Infection to Immunity
Urs F. Greber et al.
ANNUAL REVIEW OF VIROLOGY, VOL 6, 2019 (2019)
Oncolytic Effect of Adenoviruses Serotypes 5 and 6 Against U87 Glioblastoma Cancer Stem Cells
Margarita V. Romanenko et al.
ANTICANCER RESEARCH (2019)
Interaction of adenovirus with antibodies, complement, and coagulation factors
Rondine J. Allen et al.
FEBS LETTERS (2019)
Innate immunity to adenovirus: lessons from mice
Svetlana Atasheva et al.
FEBS LETTERS (2019)
A Replicating Single-Cycle Adenovirus Vaccine Against Ebola Virus
Stephanie S. Anguiano-Zarate et al.
JOURNAL OF INFECTIOUS DISEASES (2018)
Liver sinusoidal endothelial cells - gatekeepers of hepatic immunity
Shishir Shetty et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)
Hexons from adenovirus serotypes 5 and 48 differentially protect adenovirus vectors from neutralization by mouse and human serum
Andrew W. Harmon et al.
PLOS ONE (2018)
Combination of interferon-expressing oncolytic adenovirus with chemotherapy and radiation is highly synergistic in hamster model of pancreatic cancer
Amanda O. Salzwedel et al.
Oncotarget (2018)
Tel-eVax: a genetic vaccine targeting telomerase for treatment of canine lymphoma
Joseph A. Impellizeri et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2018)
Oncolytic adenovirus Ad657 for systemic virotherapy against prostate cancer
Tien V. Nguyen et al.
ONCOLYTIC VIROTHERAPY (2018)
Replicating Single-Cycle Adenovirus Vectors Generate Amplified Influenza Vaccine Responses
Catherine M. Crosby et al.
JOURNAL OF VIROLOGY (2017)
CAR: A key regulator of adhesion and inflammation
Elena Ortiz-Zapater et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2017)
Pathology in Permissive Syrian Hamsters after Infection with Species C Human Adenovirus (HAdV-C) Is the Result of Virus Replication: HAdV-C6 Replicates More and Causes More Pathology than HAdV-C5
Ann E. Tollefson et al.
JOURNAL OF VIROLOGY (2017)
Chronic hepatitis C viral infection subverts vaccine-induced T-cell immunity in humans
Christabel Kelly et al.
HEPATOLOGY (2016)
Evaluation of polymer shielding for adenovirus serotype 6 (Ad6) for systemic virotherapy against human prostate cancers
Tien V. Nguyen et al.
MOLECULAR THERAPY-ONCOLYTICS (2016)
Phase I study with ONCOS-102 for the treatment of solid tumors - an evaluation of clinical response and exploratory analyses of immune markers
Tuuli Ranki et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2016)
Treatment of melanoma with a serotype 5/3 chimeric oncolytic adenovirus coding for GM-CSF: Results in vitro, in rodents and in humans
Simona Bramante et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
The liver sinusoidal endothelium reappears after being eclipsed by the Kupffer cell: a 20th century biological delusion corrected
Clark L. Anderson
JOURNAL OF LEUKOCYTE BIOLOGY (2015)
Oncolytic adenovirus expressing interferon alpha in a syngeneic Syrian hamster model for the treatment of pancreatic cancer
Christopher J. LaRocca et al.
SURGERY (2015)
Oncolytic viruses: From bench to bedside with a focus on safety
Pascal R. A. Buijs et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2015)
Amplified and Persistent Immune Responses Generated by Single-Cycle Replicating Adenovirus Vaccines
Catherine M. Crosby et al.
JOURNAL OF VIROLOGY (2015)
IIIa deleted adenovirus as a single-cycle genome replicating vector
Catherine M. Crosby et al.
VIROLOGY (2014)
Safety and Efficacy of a Genetic Vaccine Targeting Telomerase Plus Chemotherapy for the Therapy of Canine B-Cell Lymphoma
Alessandra Gavazza et al.
HUMAN GENE THERAPY (2013)
Phase 1 studies of the safety and immunogenicity of electroporated HER2/CEA DNA vaccine followed by adenoviral boost immunization in patients with solid tumors
Claudia Marcela Diaz-Montero et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2013)
Circulating Antibodies and Macrophages as Modulators of Adenovirus Pharmacology
Reeti Khare et al.
JOURNAL OF VIROLOGY (2013)
SR-A and SREC-I Are Kupffer and Endothelial Cell Receptors for Helper-dependent Adenoviral Vectors
Pasquale Piccolo et al.
MOLECULAR THERAPY (2013)
Coagulation factor X shields adenovirus type 5 from attack by natural antibodies and complement
Zhili Xu et al.
NATURE MEDICINE (2013)
Comparison of Systemic and Mucosal Immunization with Helper-Dependent Adenoviruses for Vaccination against Mucosal Challenge with SHIV
Eric A. Weaver et al.
PLOS ONE (2013)
Generation of a novel, cyclooxygenase-2-targeted, interferon-expressing, conditionally replicative adenovirus for pancreatic cancer therapy
Leonard Armstrong et al.
AMERICAN JOURNAL OF SURGERY (2012)
Immune Response Is an Important Aspect of the Antitumor Effect Produced by a CD40L-Encoding Oncolytic Adenovirus
Iulia Diaconu et al.
CANCER RESEARCH (2012)
Characterization of Infectivity-Enhanced Conditionally Replicating Adenovectors for Prostate Cancer Radiovirotherapy
Michael J. Oneal et al.
HUMAN GENE THERAPY (2012)
Identification of Adenovirus Serotype 5 Hexon Regions That Interact with Scavenger Receptors
Reeti Khare et al.
JOURNAL OF VIROLOGY (2012)
Adenovirus Serotype 5 Neutralizing Antibodies Target both Hexon and Fiber following Vaccination and Natural Infection
Ritu R. Bradley et al.
JOURNAL OF VIROLOGY (2012)
Regulation of Virus Neutralization and the Persistent Fraction by TRIM21
W. A. McEwan et al.
JOURNAL OF VIROLOGY (2012)
MicroRNA Regulation of Oncolytic Adenovirus 6 for Selective Treatment of Castration-Resistant Prostate Cancer
Zhenwei Zhang et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Novel Adenovirus-Based Vaccines Induce Broad and Sustained T Cell Responses to HCV in Man
Eleanor Barnes et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Delivery of interferon alpha using a novel Cox2-controlled adenovirus for pancreatic cancer therapy
Leonard Armstrong et al.
SURGERY (2012)
Adenovirus receptors: implications for targeting of viral vectors
Niklas Arnberg
TRENDS IN PHARMACOLOGICAL SCIENCES (2012)
Mining the adenovirus virome for oncolytics against multiple solid tumor types
C. Y. Chen et al.
CANCER GENE THERAPY (2011)
Species D Adenoviruses as Oncolytics against B-cell Cancers
Christopher Y. Chen et al.
CLINICAL CANCER RESEARCH (2011)
Comparison of Adenoviruses as Oncolytics and Cancer Vaccines in an Immunocompetent B Cell Lymphoma Model
Eric A. Weaver et al.
HUMAN GENE THERAPY (2011)
Computational Analysis of Two Species C Human Adenoviruses Provides Evidence of a Novel Virus
Michael P. Walsh et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2011)
Generation of a Kupffer Cell-evading Adenovirus for Systemic and Liver-directed Gene Transfer
Reeti Khare et al.
MOLECULAR THERAPY (2011)
Enhanced Transduction and Replication of RGD-Fiber Modified Adenovirus in Primary T Cells
Sadhak Sengupta et al.
PLOS ONE (2011)
Characterization of species C human adenovirus serotype 6 (Ad6)
Eric A. Weaver et al.
VIROLOGY (2011)
Rapid and Efficient Clearance of Blood-borne Virus by Liver Sinusoidal Endothelium
Latha P. Ganesan et al.
PLOS PATHOGENS (2011)
A phase I clinical trial of thymidine kinase-based gene therapy in advanced hepatocellular carcinoma
B. Sangro et al.
CANCER GENE THERAPY (2010)
Production of adenovirus vectors and their use as a delivery system for influenza vaccines
Sai V. Vemula et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2010)
Infection and Killing of Multiple Myeloma by Adenoviruses
Julien S. Senac et al.
HUMAN GENE THERAPY (2010)
A Vaccine Targeting Telomerase Enhances Survival of Dogs Affected by B-cell Lymphoma
Daniela Peruzzi et al.
MOLECULAR THERAPY (2010)
Treatment of Cancer Patients With a Serotype 5/3 Chimeric Oncolytic Adenovirus Expressing GMCSF
Anniina Koski et al.
MOLECULAR THERAPY (2010)
Chimeric Adenoviral Vectors Incorporating a Fiber of Human Adenovirus 3 Efficiently Mediate Gene Transfer Into Prostate Cancer Cells
Miho Murakami et al.
PROSTATE (2010)
Telomerase and HER-2/neu as targets of genetic cancer vaccines in dogs
Daniela Peruzzi et al.
VACCINE (2010)
Requirements for Receptor Engagement during Infection by Adenovirus Complexed with Blood Coagulation Factor X
Angela C. Bradshaw et al.
PLOS PATHOGENS (2010)
Safety and Immunogenicity of the Merck Adenovirus Serotype 5 (MRKAd5) and MRKAd6 Human Immunodeficiency Virus Type 1 Trigene Vaccines Alone and in Combination in Healthy Adults
Clayton Harro et al.
CLINICAL AND VACCINE IMMUNOLOGY (2009)
Virus Binding to a Plasma Membrane Receptor Triggers Interleukin-1α-Mediated Proinflammatory Macrophage Response In Vivo
Nelson C. Di Paolo et al.
IMMUNITY (2009)
Adenovirus-mediated wild-type p53 gene transfer in combination with bronchial arterial infusion for treatment of advanced non-small-cell lung cancer, one year follow-up
Yong-song Guan et al.
JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B (2009)
Scavenger Receptor A: A New Route for Adenovirus 5
Hidde J. Haisma et al.
MOLECULAR PHARMACEUTICS (2009)
Coadministration of Telomerase Genetic Vaccine and a Novel TLR9 Agonist in Nonhuman Primates
Sridhar Dharmapuri et al.
MOLECULAR THERAPY (2009)
Redundant and Synergistic Mechanisms Control the Sequestration of Blood-born Adenovirus in the Liver
Nelson C. Di Paolo et al.
MOLECULAR THERAPY (2009)
Comparison of Replication-Competent, First Generation, and Helper-Dependent Adenoviral Vaccines
Eric A. Weaver et al.
PLOS ONE (2009)
Characterization of human adenovirus serotypes 5, 6, 11, and 35 as anticancer agents
Elena V. Shashkova et al.
VIROLOGY (2009)
Protection against Mucosal SHIV Challenge by Peptide and Helper-Dependent Adenovirus Vaccines
Eric A. Weaver et al.
VIRUSES-BASEL (2009)
Cancer, stem cells, and oncolytic viruses
Camilla Ribacka et al.
ANNALS OF MEDICINE (2008)
Adenovirus serotype 5 hexon mediates liver gene transfer
Simon N. Waddington et al.
CELL (2008)
Polyinosinic acid enhances delivery of adenovirus vectors in vivo by preventing sequestration in liver macrophages
Hidde J. Haisma et al.
JOURNAL OF GENERAL VIROLOGY (2008)
Evidence of frequent recombination among human adenoviruses
Alexander N. Lukashev et al.
JOURNAL OF GENERAL VIROLOGY (2008)
A novel adenovirus expressing Flt3 ligand enhances mucosal immunity by inducing mature nasopharyngeal-associated lymphoreticular tissue dendritic cell migration
Shinichi Sekine et al.
JOURNAL OF IMMUNOLOGY (2008)
Clearance of Adenovirus by Kupffer Cells Is Mediated by Scavenger Receptors, Natural Antibodies, and Complement
Zhili Xu et al.
JOURNAL OF VIROLOGY (2008)
Adenovirus serotype 5 hexon is critical for virus infection of heptocytes in vivo
O. Kalyuzhniy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Adenovirus-induced thrombocytopenia: the role of von Willebrand factor and P-selectin in mediating accelerated platelet clearance
Maha Othman et al.
BLOOD (2007)
A novel adenovirus type 6 (Ad6)-based hepatitis C virus vector that overcomes preexisting anti-Ad5 immunity and induces potent and broad cellular immune responses in rhesus macaques
S Capone et al.
JOURNAL OF VIROLOGY (2006)
A T-cell HCV vaccine eliciting effective immunity against heterologous virus challenge in chimpanzees
A Folgori et al.
NATURE MEDICINE (2006)
Rapid Kupffer cell death after intravenous injection of adenovirus vectors
E Manickan et al.
MOLECULAR THERAPY (2006)
Genetic targeting strategies for adenovirus
Sam C. Noureddini et al.
MOLECULAR PHARMACEUTICS (2005)
The influence of adenovirus fiber structure and function on vector development for gene therapy
SA Nicklin et al.
MOLECULAR THERAPY (2005)
Combining high selectivity of replication with fiber chimerism for effective adenoviral oncolysis of CAR-negative melanoma cells
AA Rivera et al.
GENE THERAPY (2004)
Infectivity-enhanced cyclooxygenase-2-based conditionally replicative adenoviruses for esophageal adenocarcinoma treatment
J Davydova et al.
CANCER RESEARCH (2004)
Heterogeneity of the fibre sequence in subgenus C adenoviruses
AK Adhikary et al.
JOURNAL OF CLINICAL PATHOLOGY (2004)
Analysis of adenovirus sequestration in the liver, transduction of hepatic cells, and innate toxicity after injection of fiber-modified vectors
DM Shayakhmetov et al.
JOURNAL OF VIROLOGY (2004)
Acute toxicity after high-dose systemic injection of helper-dependent adenoviral vectors into nonhuman primates
N Brunetti-Pierri et al.
HUMAN GENE THERAPY (2004)
Virotherapeutics: conditionally replicative adenoviruses for viral oncolysis
DM Nettelbeck
ANTI-CANCER DRUGS (2003)
Flexibility of the adenovirus fiber is required for efficient receptor interaction
E Wu et al.
JOURNAL OF VIROLOGY (2003)
The role of capsid-endothelial interactions in the innate immune response to adenovirus vectors
Q Liu et al.
HUMAN GENE THERAPY (2003)
Visualization of the transfer reaction: Tracking immune complexes from erythrocyte complement receptor 1 to macrophages
ML Craig et al.
CLINICAL IMMUNOLOGY (2002)
Double modification of adenovirus fiber with RGD and polylysine motifs improves coxsackievirus-adenovirus receptor-independent gene transfer efficiency
HJ Wu et al.
HUMAN GENE THERAPY (2002)
Toxicity of a first-generation adenoviral vector in rhesus Macaques
JN Lozier et al.
HUMAN GENE THERAPY (2002)
Efficient infection of primitive hematopoietic stem cells by modified adenovirus
P Yotnda et al.
GENE THERAPY (2001)
Use of quantitative TaqMan real-time PCR to track the time-dependent distribution of gene transfer vectors in vivo
NR Hackett et al.
MOLECULAR THERAPY (2000)
Efficient gene transfer into human CD34(+) cells by a retargeted adenovirus vector
DM Shayakhmetov et al.
JOURNAL OF VIROLOGY (2000)
Share Paper
